Related Experiment Video
Updated: May 19, 2026
The Use of Reverse Phase Protein Arrays (RPPA) to Explore Protein Expression Variation within Individual Renal Cell Cancers
Published on: January 22, 2013
Investigating cellular responses to novel chemotherapeutics in renal cell carcinoma using SR-FTIR spectroscopy
C Hughes1, M D Brown, N W Clarke
1Manchester Interdisciplinary Biocentre, University of Manchester, UK.
Abstract:
SR-FTIR spectroscopy was evaluated as a technique to discriminate spectral signals of cellular response at the single cell level, when cancer cells are exposed to chemotherapeutics. 5-Fluorouracil, an established drug of known mode of action, was tested against a renal carcinoma cell line (Caki-2), along with two experimental analogues of gold-based compounds. The use of unsupervised principal component analysis (PCA) failed to clearly define any distinction between control and drug treated cell spectra. Supervised principal component linear discriminant analysis (PC-LDA) did have some potential to reveal signatures of cell response and repair but again failed to distinctly discriminate groups of spectra with different drug treatments. Alternatively, clear PCA discrimination was observed in spectra from average cell populations via single point benchtop spectroscopy, probing several cells simultaneously with an increased aperture. The Caki-2 cell line initially appeared to be sensitive to the novel compounds, inducing a cellular response prior to subsequential cell recovery which was assessed by both PCA and cell viability assays.
Insights
Fourier-transform infrared (FTIR) spectroscopy struggles to differentiate single cancer cells treated with chemotherapy. However, analyzing average cell populations with FTIR shows promise for detecting drug responses and cellular recovery.
Area of Science:
- Biomedical Spectroscopy
- Cancer Research
- Chemotherapeutics
Background:
- Fourier-transform infrared (FTIR) spectroscopy offers label-free biochemical fingerprinting of cells.
- Assessing cellular responses to chemotherapeutics at the single-cell level is crucial for drug development.
- Distinguishing subtle spectral changes induced by different drugs remains a challenge.
Purpose of the Study:
- To evaluate SR-FTIR spectroscopy for discriminating single cancer cell responses to chemotherapeutics.
- To compare the efficacy of unsupervised and supervised chemometric analyses for spectral discrimination.
- To investigate the potential of FTIR spectroscopy in assessing drug-induced cellular response and recovery.
Main Methods:
- Single-cell SR-FTIR spectroscopy was applied to renal carcinoma (Caki-2) cells.
- Cells were exposed to 5-Fluorouracil and two experimental gold-based compounds.
- Unsupervised Principal Component Analysis (PCA) and supervised Principal Component Linear Discriminant Analysis (PC-LDA) were employed.
- Benchtop spectroscopy with an increased aperture was used to analyze average cell populations.
Main Results:
- Unsupervised PCA failed to distinguish between control and drug-treated single cells.
- PC-LDA showed potential for detecting cellular response and repair but lacked distinct discrimination between drug treatments.
- Clear discrimination was achieved when analyzing average cell populations using benchtop FTIR.
- Caki-2 cells exhibited initial sensitivity to novel compounds, followed by recovery, as indicated by PCA and viability assays.
Conclusions:
- Single-cell SR-FTIR spectroscopy, with current analysis methods, has limitations in discriminating specific chemotherapeutic effects.
- Analyzing average cell populations via benchtop FTIR spectroscopy provides a more robust method for detecting drug-induced cellular changes.
- FTIR spectroscopy shows potential for monitoring cancer cell sensitivity and recovery dynamics in response to novel compounds.
More Related Videos
11:05High-definition Fourier Transform Infrared (FT-IR) Spectroscopic Imaging of Human Tissue Sections towards Improving Pathology
Published on: January 21, 2015
07:37An Integrated Raman Spectroscopy and Mass Spectrometry Platform to Study Single-Cell Drug Uptake, Metabolism, and Effects
Published on: January 9, 2020
